| Title | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
| Abbreviation | Prog. Neuro-Psychopharmacol. Biol. Psychiatry |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biological Psychiatry (Q1); Pharmacology (Q1) |
| h-index | 142 |
| Overall Rank/Ranking | 2044 |
| SCImago Journal Rank (SJR) | 1.543 |
| Impact Score | 6.11 |
| Publisher | Elsevier Inc. |
| Country | United States |
| ISSN | 18784216, 02785846 |
| Best Quartile | Q1 |
| Coverage History | 1982-2023 |
Progress in Neuro-Psychopharmacology and Biological Psychiatry is a journal covering the technologies/fields/categories related to Biological Psychiatry (Q1); Pharmacology (Q1). It is published by Elsevier Inc.. The overall rank of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 2044. According to SCImago Journal Rank (SJR), this journal is ranked 1.543. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 142. The best quartile for this journal is Q1.
The ISSN of Progress in Neuro-Psychopharmacology and Biological Psychiatry journal is 18784216, 02785846. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Progress in Neuro-Psychopharmacology and Biological Psychiatry is cited by a total of 4775 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 6.11, which is computed in 2023 as per its definition. Progress in Neuro-Psychopharmacology and Biological Psychiatry IF is increased by a factor of 1.26 and approximate percentage change is 25.98% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 6.11. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6.11 |
| 2021 | 4.85 |
| 2020 | 4.72 |
| 2019 | 4.51 |
| 2018 | 4.45 |
| 2017 | 4.37 |
| 2016 | 4.50 |
| 2015 | 4.98 |
| 2014 | 4.21 |
Progress in Neuro-Psychopharmacology and Biological Psychiatry has an h-index of 142. It means 142 articles of this journal have more than 142 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 18784216, 02785846. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Progress in Neuro-Psychopharmacology and Biological Psychiatry is 2044. According to SCImago Journal Rank (SJR), this journal is ranked 1.543. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.543 |
| 2021 | 1.370 |
| 2020 | 1.716 |
| 2019 | 1.714 |
| 2018 | 1.484 |
| 2017 | 1.714 |
| 2016 | 1.929 |
| 2015 | 1.819 |
| 2014 | 1.789 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2044 |
| 2021 | 2459 |
| 2020 | 1767 |
| 2019 | 1755 |
| 2018 | 2285 |
| 2017 | 1802 |
| 2016 | 1514 |
| 2015 | 1714 |
| 2014 | 1720 |
Progress in Neuro-Psychopharmacology and Biological Psychiatry is published by Elsevier Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1982-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Progress in Neuro-Psychopharmacology and Biological Psychiatry is Prog. Neuro-Psychopharmacol. Biol. Psychiatry. This abbreviation ('Prog. Neuro-Psychopharmacol. Biol. Psychiatry') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biological Psychiatry (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Progress in Neuro-Psychopharmacology and Biological Psychiatry latest impact IF is 6.11. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 6.11 (2022) and 4.21 (2014), respectively, in the last 9 years. Moreover, its average IS is 4.74 in the previous 9 years.
The Progress in Neuro-Psychopharmacology and Biological Psychiatry has an SJR (SCImago Journal Rank) of 1.543, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.929 in 2016 and the lowest being 1.370 in 2021. Furthermore, the average SJR of the Progress in Neuro-Psychopharmacology and Biological Psychiatry over the previous 9-year period stands at 4.74.
The latest h-index of the Progress in Neuro-Psychopharmacology and Biological Psychiatry is 142.
The Progress in Neuro-Psychopharmacology and Biological Psychiatry is published by the Elsevier Inc., with its country of publication being the United States.
The Progress in Neuro-Psychopharmacology and Biological Psychiatry is currently ranked 2044 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1514 in 2016 and its lowest position of 2459 in 2021.
The standard ISO4 abbreviation for the Progress in Neuro-Psychopharmacology and Biological Psychiatry is Prog. Neuro-Psychopharmacol. Biol. Psychiatry.
Progress in Neuro-Psychopharmacology and Biological Psychiatry is classified as a journal that the Elsevier Inc. publishes.
The Progress in Neuro-Psychopharmacology and Biological Psychiatry encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Progress in Neuro-Psychopharmacology and Biological Psychiatry is assigned the following International Standard Serial Numbers (ISSN): 18784216, 02785846.
The best quartile for the Progress in Neuro-Psychopharmacology and Biological Psychiatry is Q1 (2022).
The Progress in Neuro-Psychopharmacology and Biological Psychiatry coverage history can be summarized as follows: 1982-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Clinical Medicine and Research | journal | 16602 | Marshfield Clinic | 60 | 1.06 |
| Journal of Competition Law and Economics | journal | 14815 | Oxford University Press | 29 | 0.72 |
| CESifo Economic Studies | journal | 14012 | Oxford University Press | 32 | 1.70 |
| Entrepreneurship Theory and Practice | journal | 338 | Wiley-Blackwell | 185 | 12.75 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Exploration Geophysics | journal | 16383 | Taylor and Francis Ltd. | 48 | 1.17 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Journal des Professionnels de l'Enfance | journal | 27577 | TPMA | 2 | 0.00 |
| Metascience | journal | 13645 | Springer Nature | 3 | 0.13 |
| Himalayan Geology | journal | 14451 | Wadia Institute of Himalayan Geology | 16 | 1.41 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6.11 |
| 2021 | 4.85 |
| 2020 | 4.72 |
| 2019 | 4.51 |
| 2018 | 4.45 |
| 2017 | 4.37 |
| 2016 | 4.50 |
| 2015 | 4.98 |
| 2014 | 4.21 |
